Hasil Pencarian - Sanjeev Kaul

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Intraoperative REBOA for a massive zone 1 retroperitoneal hematoma

    Intraoperative REBOA for a massive zone 1 retroperitoneal hematoma oleh Arthur Berg, Alexander Fortgang, Sanjeev Kaul

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Bradycardia after Tube Thoracostomy for Spontaneous Pneumothorax

    Bradycardia after Tube Thoracostomy for Spontaneous Pneumothorax oleh Yomi Fashola, Sanjeev Kaul, Douglas Finefrock

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Delayed evolving epidural hematoma in the setting of a depressed skull fracture: A case report and review of the literature

    Delayed evolving epidural hematoma in the setting of a depressed skull fracture: A case report and review of the literature oleh Arthur Berg, Brett Voigt, Sanjeev Kaul

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Use of adjuvant hyperbaric oxygen therapy in a patient with traumatic inoculation of mucormycosis resulting in extremity amputation

    Use of adjuvant hyperbaric oxygen therapy in a patient with traumatic inoculation of mucormycosis resulting in extremity amputation oleh Arthur Berg, Sanjeev Kaul, Michelle Kruse, Stanton Nielsen

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Untreatable Surgical Site Infection: Consider Pyoderma Gangrenosum

    Untreatable Surgical Site Infection: Consider Pyoderma Gangrenosum oleh Ilan Berlinrut, MD, Nitasha Bhatia, MD, Jonathan M. Josse, MD, MSc, David de Vinck, DO, Sanjeev Kaul, MD

    Diterbitkan 2014-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms

    313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms oleh Xiaoyu Zhang, Sanjeev Kaul, Paul Moore, Jason Luke, Bartosz Chmielowski, Hedy Kindler, Francine Chen, George Blumenschein, Erika Hamilton, Shakeela Bahadur, Cesar Santa-Maria, Janine Koucheki, Jichao Sun, John Muth, Patrick Kaminker, Bradley Sumrow

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

    Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial oleh Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: